We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Gene Sequencing Strategy Quickly Identifies Adenovirus Type

By Biotechdaily staff writers
Posted on 29 Oct 2007
A new gene sequencing strategy identifies adenovirus type in two days compared with the previous method that took weeks.

The rapid and accurate new molecular typing strategy has been used to conduct one of the most comprehensive studies of adenoviruses ever performed in the United States. More...
Adenoviruses commonly cause respiratory illnesses and infections of the stomach, intestine, eyes, and bladder. Sometimes they cause epidemics and deaths. The new findings, from the extensive adenovirus epidemiologic data collected in the United States, reveal that adenoviruses are frequently associated with hospitalizations and that some of these viruses may cause more severe disease than others.

The method, originally developed by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), will help public health officials better understand adenovirus outbreaks in communities and other settings where people are in close contact, such as hospitals and long-term care facilities. It also will help clinicians know what type is causing the infection in order to use the appropriate antiviral treatment. Some adenovirus strains, particularly those considered as emerging pathogens, are more often associated with severe disease and death.

In an effort to understand how adenovirus infection is caused and spread in different settings and populations, Gregory Gray, M.D., from the University of Iowa (Iowa City, IA, USA), and his colleagues analyzed clinical adenovirus-positive samples and patient data from 22 military and civilian medical facilities over a 25-month period. They characterized the strains of 2,237 adenovirus-positive specimens and compared their sequences with those of the 51 recognized strains that infect humans.

They found that the distribution of adenovirus types varies by patient age, disease state, and geographic location. In addition, adenovirus type 21 infections, which may cause more disease, have become more common. Fifty percent of the clinical adenovirus isolates among civilians were associated with hospitalization, about 20% with a chronic disease condition, 11% with bone marrow or solid organ transplantation, and 4% with a cancer diagnosis.

Children under seven years of age, people with an underlying chronic disease, and those with recent organ transplantation are at greater risk of adenovirus infection and disease.
A relatively high number of transplantation patients were found to have infections with multiple adenovirus isolates over time.

The investigators said that quickly recognizing the adenovirus type is the key to starting the appropriate antiviral therapy, controlling outbreaks, and understanding the association of adenoviruses with a number of chronic disease conditions. Dr. Gray and his colleagues are using the molecular typing technique to help clinicians do just that.

This study was funded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD; USA), part of the National Institutes of Health. It was published in the October 2007 issue of the journal Clinical Infectious Diseases.


Related Links:
University of Iowa
U.S. Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.